Armistice Capital »

Briacell Therapeutics Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Briacell Therapeutics Corp shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $553k 537k 1.03

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Briacell Therapeutics Corp

Citadel Advisors
Armistice Capital
Cable Car Capital
Empery Asset Management
Hudson Bay Capital Management
Warberg Asset Management
Clear Street Group
Iridian Asset Management
Boothbay Fund Management
FNY Investment Advisers

View all funds holding Briacell Therapeutics Corp